News
Newly launched Vicarius Pharma secures CHF21 million financing
www.startupticker.ch
Vicarius Pharma is led by CEO Hans Peter Hasler (former COO of Elan and Biogen), and a team of senior executives with exceptional European commercialization experience. James Mullen, CEO of Patheon and former chief executive officer of Biogen, is an investor in this Series A round and executive ...
sortiert nach Relevanz / Datum